Our research has shown decreasing in VCAM-1 expression in GBM spheroids and also in U-87 MG glioblastoma cells to G721-0282 treatment, mainly at concentrations of 100 − 25 μM, which could be explained by VCAM-1/IL-1β dependence. The gene discussed is IL1B; the disease is glioblastoma.